Company news
Nutriband Inc. news in 2026
Nutriband Inc.'s news releases, calls and decks from 2026, newest first.
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
October 13, 2026
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
October 8, 2026
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
October 1, 2026
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
September 29, 2026
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
September 25, 2026
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
September 22, 2026
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
September 9, 2026
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
September 8, 2026
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
August 13, 2026
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
May 15, 2026
Annual Report for Fiscal Year Ending January 31, 2026 (Form 10-K)
April 29, 2026
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
April 22, 2026
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
March 29, 2026
Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica
March 17, 2026
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
February 17, 2026
Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
January 30, 2026